WASHINGTON, D.C., July 30, 2005.

Empatha, Inc., elected Dr. Gary Noble as Chairman of its newly formed board of directors, effective immediately.

“We are delighted that Gary Noble has assumed the role of chairman of the board,” said William C. Parra, Empatha’s interim president and chief executive officer. “Gary brings a wealth of experience and knowledge in the areas of public health and the pharmaceutical industry. This knowledge will be extremely beneficial to Empatha.”

Noble is the former vice president for medical and public health affairs for Johnson & Johnson. Prior to that, Dr. Noble spent 29 years with the Centers for Disease Control and Prevention in various key positions, including deputy director of the Atlanta agency and director, CDC government affairs in Washington, D.C. Dr. Noble is a graduate of Harvard Medical School and is board certified in preventive medicine.

The Empatha board of directors also elected Sarah Harrison, vice president, AstraZeneca Pharmaceuticals, as vice chair, and Thomas Terragno, principal, Booz Allen Hamilton, as secretary-treasurer.

Empatha, Inc. is a premium quality contact center focusing on interactive communications of sensitive health and human services issues. It offers a full range of services to federal and state governments, the pharmaceutical industry, contract research organizations, biotechnology companies, and social service organizations. The services include test results counseling, research study enrollment, research study implementation and support training, curriculum design and implementation, technical assistance programs, and direct consumer response.

Empatha, Inc., is a wholly-owned subsidiary of the American Social Health Association (ASHA), a nonprofit organization based in Research Triangle Park. ASHA was founded in 1914 and is dedicated to the education and prevention of sexually transmitted infections.